Xoma reported $-10.08M in EBIT for its fiscal quarter ending in June of 2024.





Ebit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Agenus USD 14.4M 19.26M Dec/2025
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
Ardelyx USD 5.1M 2.02M Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
BioMarin Pharmaceutical USD 129.65M 68.74M Mar/2026
Celldex Therapeutics USD -84.44M 2.72M Mar/2026
Curis USD -7.88M 4.31M Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Incyte USD 344.17M 39.71M Mar/2026
MacroGenics USD -12.1M 32.26M Dec/2025
Novartis USD 4.18B 118M Mar/2026
Novartis USD 4.06B 413M Dec/2025
Pfizer USD 4.99B 340M Mar/2026
Prothena USD -27.21M 12.55M Dec/2025
Regeneron Pharmaceuticals USD 744.8M 153.8M Mar/2026
Xoma USD -10.08M 4.4M Jun/2024